- Home
- WVE vs MFH Comparison
WVE vs MFH Comparison
Compare WVE & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- MFH
- Stock Information
- Founded
- WVE 2012
- MFH 2011
- Country
- WVE Singapore
- MFH United States
- Employees
- WVE N/A
- MFH N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- WVE Health Care
- MFH Finance
- Exchange
- WVE Nasdaq
- MFH Nasdaq
- Market Cap
- WVE 915.6M
- MFH 822.0M
- IPO Year
- WVE 2015
- MFH N/A
- Fundamental
- Price
- WVE $8.31
- MFH $10.39
- Analyst Decision
- WVE Strong Buy
- MFH
- Analyst Count
- WVE 14
- MFH 0
- Target Price
- WVE $20.79
- MFH N/A
- AVG Volume (30 Days)
- WVE 3.6M
- MFH 330.5K
- Earning Date
- WVE 11-07-2025
- MFH 12-04-2025
- Dividend Yield
- WVE N/A
- MFH N/A
- EPS Growth
- WVE N/A
- MFH N/A
- EPS
- WVE N/A
- MFH N/A
- Revenue
- WVE $93,946,000.00
- MFH $960,967.00
- Revenue This Year
- WVE N/A
- MFH N/A
- Revenue Next Year
- WVE $6.26
- MFH N/A
- P/E Ratio
- WVE N/A
- MFH N/A
- Revenue Growth
- WVE N/A
- MFH 65.39
- 52 Week Low
- WVE $5.28
- MFH $1.20
- 52 Week High
- WVE $16.74
- MFH $36.77
- Technical
- Relative Strength Index (RSI)
- WVE 56.37
- MFH 42.48
- Support Level
- WVE $8.18
- MFH $9.08
- Resistance Level
- WVE $9.75
- MFH $12.35
- Average True Range (ATR)
- WVE 0.64
- MFH 2.43
- MACD
- WVE 0.14
- MFH -0.80
- Stochastic Oscillator
- WVE 48.94
- MFH 11.32
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.